Cerner Co. (CERN) Director Linda M. Dillman Sells 4,600 Shares
Cerner Co. (NASDAQ:CERN) Director Linda M. Dillman sold 4,600 shares of the business’s stock in a transaction on Monday, May 22nd. The shares were sold at an average price of $64.69, for a total transaction of $297,574.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Shares of Cerner Co. (NASDAQ:CERN) traded up 0.75% during mid-day trading on Monday, reaching $64.58. 2,814,720 shares of the company’s stock traded hands. Cerner Co. has a 12 month low of $47.01 and a 12 month high of $67.50. The firm has a 50 day moving average price of $61.61 and a 200-day moving average price of $54.55. The stock has a market cap of $21.34 billion, a PE ratio of 33.29 and a beta of 1.05.
Cerner (NASDAQ:CERN) last issued its quarterly earnings data on Thursday, April 27th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.06. Cerner had a net margin of 13.27% and a return on equity of 18.16%. The business had revenue of $1.26 billion during the quarter, compared to analysts’ expectations of $1.23 billion. During the same quarter in the previous year, the company earned $0.53 EPS. The business’s revenue was up 10.7% on a year-over-year basis. On average, analysts predict that Cerner Co. will post $2.51 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: “Cerner Co. (CERN) Director Linda M. Dillman Sells 4,600 Shares” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2017/05/22/cerner-co-cern-director-linda-m-dillman-sells-4600-shares.html.
CERN has been the topic of several research analyst reports. Jefferies Group LLC restated a “buy” rating and set a $63.00 price target on shares of Cerner in a report on Tuesday, February 14th. Deutsche Bank AG cut shares of Cerner from a “buy” rating to a “hold” rating in a report on Tuesday, January 31st. Canaccord Genuity restated a “buy” rating and set a $63.00 price target on shares of Cerner in a report on Friday, January 27th. Cantor Fitzgerald restated an “overweight” rating and set a $66.00 price target on shares of Cerner in a report on Wednesday, February 22nd. Finally, Citigroup Inc cut shares of Cerner from a “buy” rating to a “neutral” rating in a report on Friday, February 24th. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, fifteen have issued a hold rating and nine have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $64.33.
Hedge funds have recently modified their holdings of the company. BlackRock Inc. boosted its stake in shares of Cerner by 3,008.5% in the first quarter. BlackRock Inc. now owns 18,298,722 shares of the company’s stock valued at $1,076,881,000 after buying an additional 17,710,062 shares during the period. Fiduciary Management Inc. WI acquired a new stake in shares of Cerner during the fourth quarter valued at $239,174,000. UBS Group AG boosted its stake in shares of Cerner by 1,843.1% in the first quarter. UBS Group AG now owns 5,306,053 shares of the company’s stock valued at $312,261,000 after buying an additional 5,032,976 shares during the period. Bank of New York Mellon Corp boosted its stake in shares of Cerner by 29.9% in the first quarter. Bank of New York Mellon Corp now owns 14,745,663 shares of the company’s stock valued at $867,783,000 after buying an additional 3,391,745 shares during the period. Finally, Veritas Asset Management LLP acquired a new stake in shares of Cerner during the first quarter valued at $186,725,000. Institutional investors and hedge funds own 80.58% of the company’s stock.
Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.
Receive News & Ratings for Cerner Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner Co. and related companies with MarketBeat.com's FREE daily email newsletter.